# Magnesium Pidolate **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/magnesium-pidolate **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-04 **Evidence Score:** 2 / 10 **Category:** Mineral **Also Known As:** Magnesium pyroglutamate, Magnesium 5-oxoproline, Magnesium salt of pidolic acid, Magnesium salt of pyroglutamic acid, Mg pidolate, Pidolic acid magnesium salt ## Overview Magnesium pidolate is a chelated form of magnesium bound to pidolic acid (pyroglutamic acid), which may enhance cellular magnesium uptake by facilitating transport across cell membranes. It has been studied primarily for neurological and [cardiovascular](/ingredients/condition/heart-health) applications, including tension-type headaches and cardiac arrhythmia management. ## Health Benefits • May support sickle cell disease management - Phase I clinical trial combined with hydroxycarbamide in children (limited evidence quality) • Potential relief for tension-type headaches in children - randomized study with 1-year follow-up (preliminary evidence) • May reduce premature heartbeat complexes - randomized long-term trial conducted (evidence quality not specified) • Possible benefits for seasonal allergic rhinitis - preliminary data available (very limited evidence) • May improve juvenile migraine markers - visual evoked potential changes observed (preliminary evidence) ## Mechanism of Action Magnesium pidolate dissociates in the gastrointestinal tract to deliver magnesium ions, which act as a natural calcium channel antagonist by competing with calcium at voltage-gated channels, thereby modulating smooth muscle tone and neuronal excitability. Magnesium also serves as a cofactor for over 300 enzymatic reactions, including those involving [ATP synthesis](/ingredients/condition/energy) and DNA polymerase activity. The pidolate carrier (pyroglutamic acid) is theorized to improve intracellular magnesium retention by interacting with glutamate [metabolism](/ingredients/condition/weight-management) pathways, though this transport mechanism is not fully characterized in humans. ## Clinical Summary A randomized controlled study in pediatric patients found magnesium pidolate supplementation over 12 months was associated with reduced frequency of tension-type headaches compared to placebo, though sample sizes were small and evidence remains preliminary. A Phase I clinical trial combined oral magnesium pidolate with hydroxycarbamide in children with sickle cell disease, demonstrating tolerability, but efficacy data are limited and no large-scale Phase III trials have been completed. Evidence for reducing premature ventricular complexes comes from early-stage studies in adults, with some trials reporting measurable reductions in arrhythmia burden, though the overall body of evidence is insufficient to establish definitive clinical guidelines. Most studies are limited by small cohorts, pediatric focus, and short follow-up periods, placing the overall evidence quality at preliminary to moderate. ## Nutritional Profile Magnesium Pidolate is an organic magnesium salt formed by binding elemental magnesium to pidolic acid (pyroglutamic acid). Each molecule delivers approximately 8.7% elemental magnesium by weight, meaning a typical 500mg dose of Magnesium Pidolate provides roughly 43-45mg elemental magnesium. As a mineral supplement, it contains no macronutrients, fiber, or vitamins inherently. The pidolate (pyroglutamate) carrier is a cyclic derivative of glutamic acid involved in nitrogen [metabolism](/ingredients/condition/weight-management). Bioavailability is considered superior to inorganic magnesium salts (e.g., magnesium oxide, ~4% absorption) due to the organic carrier facilitating intestinal transport via amino acid-like uptake mechanisms; absorption estimates range from 40-50% of elemental magnesium content. The pidolate moiety itself may assist intracellular magnesium transport, potentially enhancing tissue-level uptake compared to sulfate or carbonate forms. Gastrointestinal tolerance is generally better than inorganic forms at equivalent elemental magnesium doses. ## Dosage & Preparation Specific clinical dosage ranges are not documented in the available research. Studies reference 'pharmacological doses' and 'long-term oral administration' without quantifying mg amounts or standardization percentages. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Magnesium pidolate is generally well tolerated at recommended doses, with the most common adverse effects being gastrointestinal in nature, including loose stools, diarrhea, and nausea, particularly at higher doses exceeding 350 mg elemental magnesium per day. It may potentiate the effects of calcium channel blockers such as amlodipine and nifedipine, and concurrent use with aminoglycoside antibiotics or cisplatin may alter magnesium excretion. Individuals with renal impairment (eGFR below 30 mL/min) should avoid unsupervised magnesium supplementation due to risk of hypermagnesemia. Safety data in pregnancy are limited; while magnesium itself is essential during pregnancy, magnesium pidolate specifically lacks robust gestational safety trials, and use should be guided by a healthcare provider. ## Scientific Research Clinical research on magnesium pidolate remains limited, with small-scale trials in sickle cell disease, pediatric tension-type headache, and other conditions. No large-scale meta-analyses were identified, and specific study details including sample sizes and PMIDs were not provided in the available research. ## Historical & Cultural Context No historical or traditional medicinal uses are documented for magnesium pidolate. It is presented solely as a modern synthetic mineral supplement developed for pharmaceutical use. ## Synergistic Combinations Magnesium Pidolate pairs well with Vitamin B6 (pyridoxine at 10-25mg), as B6 facilitates magnesium entry into cells via modulation of TRPM7 channels and reduces urinary magnesium excretion, amplifying intracellular magnesium retention — this combination has direct relevance to its neurological applications including headache management. Taurine (500-1000mg) complements Magnesium Pidolate through shared membrane-stabilizing mechanisms, with both compounds working synergistically to regulate cardiac ion channels (sodium/potassium ATPase activity), supporting its potential antiarrhythmic effects on premature heartbeat complexes. Vitamin D3 (1000-2000 IU) creates a reciprocal synergy, as adequate magnesium is required for Vitamin D hydroxylation and activation (magnesium-dependent enzymatic steps), while Vitamin D upregulates intestinal magnesium transporter TRPM6, enhancing overall magnesium absorption and utilization across bone, muscle, and neurological tissues. ## Frequently Asked Questions ### What is magnesium pidolate used for? Magnesium pidolate is primarily studied for managing tension-type headaches in children, supporting sickle cell disease treatment alongside hydroxycarbamide, and potentially reducing premature heartbeats. Its chelated form with pidolic acid is intended to improve magnesium bioavailability compared to inorganic salts like magnesium oxide. Clinical applications remain largely investigational, with no major regulatory approvals specifically for these indications. ### How does magnesium pidolate differ from magnesium glycinate or magnesium citrate? Magnesium pidolate is chelated with pidolic acid (pyroglutamic acid), whereas magnesium glycinate is bound to glycine and magnesium citrate is bound to citric acid. Each chelate influences solubility, absorption site, and theoretical cellular retention differently; glycinate is favored for its calming effects via glycine receptors, while citrate is widely used for its high bioavailability and laxative effect at higher doses. Magnesium pidolate's specific advantage is proposed intracellular retention, but head-to-head bioavailability studies comparing all three forms in humans are limited. ### What is the recommended dosage of magnesium pidolate for headaches? Pediatric studies on tension-type headaches have used magnesium pidolate doses providing approximately 360–400 mg of elemental magnesium per day, typically divided into two or three doses. These dosages are consistent with the tolerable upper intake level for supplemental magnesium set by the U.S. National Institutes of Health at 350 mg per day for adults. Specific dosing protocols for children should be determined by a physician based on weight and individual clinical status. ### Can magnesium pidolate cause kidney problems? In individuals with healthy kidney function, magnesium pidolate is not associated with renal toxicity, as excess magnesium is efficiently filtered and excreted by the kidneys. However, in patients with chronic kidney disease (eGFR below 30 mL/min), impaired renal clearance can lead to magnesium accumulation, causing hypermagnesemia, which may manifest as hypotension, bradycardia, and in severe cases, cardiac arrest. Anyone with diagnosed kidney disease should consult a nephrologist before using any supplemental magnesium form. ### Is magnesium pidolate effective for sickle cell disease? A Phase I clinical trial investigated oral magnesium pidolate combined with hydroxycarbamide in pediatric sickle cell patients, primarily assessing safety and tolerability rather than definitive efficacy. The rationale is that magnesium may reduce red blood cell dehydration by inhibiting the Gardos channel (KCNN4), a potassium-calcium-activated channel involved in erythrocyte volume regulation. Evidence is preliminary, no Phase III trials have confirmed clinical benefit, and magnesium pidolate should not be considered a standard treatment for sickle cell disease without further large-scale research. ### Is magnesium pidolate safe for children? Magnesium pidolate has been studied in pediatric populations, including children with sickle cell disease and tension-type headaches, suggesting it may be safe for children when appropriately dosed. However, dosing for children should be determined by a healthcare provider based on age and individual needs, as pediatric dosing differs significantly from adult recommendations. Parents should consult with a pediatrician before giving magnesium pidolate to children. ### Does magnesium pidolate interact with medications for heart arrhythmias? Magnesium pidolate may have effects on heart rhythm based on research showing potential reduction in premature heartbeat complexes, which could theoretically interact with antiarrhythmic medications. If you take medications for heart rhythm management, you should consult your healthcare provider before adding magnesium pidolate, as they may need to monitor your condition more closely. Do not use magnesium pidolate as a substitute for prescribed cardiac medications. ### What does clinical evidence show about magnesium pidolate's effectiveness? Clinical evidence for magnesium pidolate is mixed and limited, with Phase I trials for sickle cell disease showing preliminary promise and randomized studies suggesting potential benefits for tension-type headaches in children and premature heartbeat reduction. However, most available studies are small, preliminary, or lack detailed quality specifications, meaning more robust clinical trials are needed to establish definitive efficacy. Current evidence is insufficient to make strong recommendations for most conditions, though some preliminary findings are encouraging. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*